CD4 + T cells impair tumor growth through IL-3 and TNF-dependent vascular damage
Science · 18.06.2026 · 392 (6804)
DOI: 10.1126/science.ads7910 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 18.06.2026. Verfasst von Qiaoshi Lian und 13 weiteren Autor:innen. Beteiligte Einrichtung: Lymphocyte Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health…. Hauptthemen laut MEDLINE: CD4-Positive T-Lymphocytes, Neovascularization, Pathologic, Tumor Necrosis Factor-alpha, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, National Cancer Institute, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Most cancer immunotherapy strategies are focused on direct tumor killing by immune cells, especially T lymphocytes. Clinical and conceptual limitations of these approaches create a need for additional strategies. We identified a tumor stroma–targeting mechanism in which tumor antigen–specific CD4 + T cells inhibit tumor growth through myeloid cell and tumor necrosis factor (TNF)–dependent vascular damage. Multiplex immunofluorescence and single-cell and tissue transcriptomics showed that CD4 + T cells trigger the formation of perivascular myeloid cell clusters containing “classically activated” macrophages that produce TNF in response to T cell–derived interleukin-3. TNF causes intratumoral endothelial damage and blood supply disruption, which are associated with localized tumor cell death. Thus, intratumoral antigen-triggered T cell activation can mediate antitumor effects without direct recognition of living tumor cells, thereby avoiding many of the inhibitory mechanisms that limit anti-tumor immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Lymphocyte Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
- Laboratory of Immune Cell Biology and Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
- Single Cell Analysis Facility, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
- Molecular Histopathology Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
ORCID-Profile: Qiaoshi Lian, Jatinder Singh, Qiang Chen, Jennifer Matta, Waipan Chan, Mariah Balmaceno-Criss, Melanie S Vacchio, Weiming Yu, Elijah Edmondson, Michael C Kelly, Ronald N Germain, Rémy Bosselut
Förderung
- Intramural NIH HHS
- National Cancer Institute
- National Institute of Allergy and Infectious Diseases
- Frederick National Laboratory for Cancer Research
Zitieren
APA
Lian, Q., Nie, J., Singh, J., Chen, Q., Matta, J., Chan, W., Balmaceno-Criss, M., Vacchio, M. S., Yu, W., Clark, A. D., Edmondson, E., Kelly, M. C., Germain, R. N., & Bosselut, R. (2026). CD4 + T cells impair tumor growth through IL-3 and TNF-dependent vascular damage. Science, 392(6804). https://doi.org/10.1126/science.ads7910
Vancouver
Lian Q, Nie J, Singh J, Chen Q, Matta J, Chan W, et al. CD4 + T cells impair tumor growth through IL-3 and TNF-dependent vascular damage. Science. 2026;392(6804). doi:10.1126/science.ads7910
BibTeX
@article{Lian2026,
author = {Lian, Qiaoshi and Nie, Jia and Singh, Jatinder and Chen, Qiang and Matta, Jennifer and Chan, Waipan and Balmaceno-Criss, Mariah and Vacchio, Melanie S and Yu, Weiming and Clark, Alexander D and Edmondson, Elijah and Kelly, Michael C and Germain, Ronald N and Bosselut, Rémy},
title = {CD4 + T cells impair tumor growth through IL-3 and TNF-dependent vascular damage},
journal = {Science},
year = {2026},
volume = {392},
number = {6804},
doi = {10.1126/science.ads7910}
}
EUVIMED